Aphelion Capital has 1 portfolio company on record at Recent Funding. It led 1 of the 2 rounds it joined. Its most recent investment on record is Biolinq's $100M Series B+ round in April 2025, alongside Taisho Pharmaceutical Holdings, RiverVest, M Ventures and 5 others. That company is in Health and bio. It has co-invested with M Ventures, LifeSci Venture Partners and Hikma Ventures, most often M Ventures (2 rounds).

What Aphelion Capital invests in

• Health and bio · 1 · 100%
• Data and analytics · 1 · 100%

How Aphelion Capital invests

Share is of the 2 rounds on Recent Funding that name Aphelion Capital. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Aphelion Capital portfolio companies

• BBiolinq$100MSeries B+ · Apr 2025

Most frequent co-investors

• MM Ventures2 shared rounds · last Apr 22, 2025
• LLifeSci Venture Partners2 shared rounds · last Apr 22, 2025
• HHikma Ventures2 shared rounds · last Apr 22, 2025
• AAlpha Wave Ventures1 shared round · last Apr 22, 2025
• TTaisho Pharmaceutical Holdings1 shared round · last Apr 22, 2025
• RRiverVest1 shared round · last Apr 22, 2025
• FFeatures Capital1 shared round · last Apr 22, 2025
• AAXA Alternative Investments1 shared round · last Apr 22, 2025
• JJDRF T1D Fund1 shared round · last Mar 28, 2019

Similar investors

• 221501 company · 1 deal in 12 mo
• CCove Hill Partners1 company · 1 deal in 12 mo
• DDSW Ventures1 company · 1 deal in 12 mo
• FF2 Venture Capital1 company · 1 deal in 12 mo
• NNorth Bridge Venture Partners & Growth Equity1 company
• SShamrock Capital1 company

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

Portfolio companies are the companies on Recent Funding with a round that lists Aphelion Capital, which is a subset of its real portfolio. API: /api/v1/investors/aphelion-capital (get a free API key). More: the most active VC firms and new venture capital funds.